Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation

Immunity

Volumn 18, Issue 2, 2003, Pages 255-264

  Holler, Phillip D ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDOMA; IN VITRO STUDY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; T LYMPHOCYTE ACTIVATION;

EID: 0037331525     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00019-0     Document Type: Article

References (61)

1. Alam S.M., Davies G.M., Lin C.M., Zal T., Nasholds W., Jameson S.C., Hogquist K.A., Gascoigne N.R., Travers P.J. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity. 10:1999;227-237.
2. Alexander J., Payne J.A., Murray R., Frelinger J.A., Cresswell P. Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics. 29:1989;380-399.
3. Al-Ramadi B.K., Jelonek M.T., Boyd L.F., Margulies D.H., Bothwell A.L.M. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:1995;662-673.
4. Baker B.M., Wiley D.C. αβ T cell receptor ligand-specific oligomerization revisited. Immunity. 14:2001;681-692.
5. Baker M.B., Gagnon J.S., Biddison E.W., Wiley C.D. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface. implications for TCR signaling Immunity. 13:2000;475-484.
6. Boniface J.J., Reich Z., Lyons D.S., Davis M.M. Thermodynamics of T cell receptor binding to peptide-MHC. evidence for a general mechanism of molecular scanning Proc. Natl. Acad. Sci. USA. 96:1999;11446-11451.
7. + T cells in the thymus Immunity. 12:2000;409-418.
8. Cai Z., Sprent J. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179:1994;2005-2015.
9. Cai Z., Sprent J. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro. J. Exp. Med. 183:1996;2247-2257.
10. Cai Z., Kishimoto H., Brunmark A., Jackson M.R., Peterson P.A., Sprent J. Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J. Exp. Med. 185:1997;641-651.
11. 50) of an enzymatic reaction. Biochem. Pharm. 22:1973;3099-3108.
12. Cho B.K., Lian K.C., Lee P., Brunmark A., McKinley C., Chen J., Kranz D.M., Eisen H.N. Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. Proc. Natl. Acad. Sci. USA. 98:2001;1723-1727.
13. Coombs D., Kalergis A.M., Nathenson S.G., Wofsy C., Goldstein B. Activated TCRs remain marked for internalization after dissociation from pMHC. Nat. Immunol. 3:2002;926-931.
14. Corr M., Slanetz A.E., Boyd L.F., Jelonek M.T., Khilko S., Al-Ramadi B.K., Kim Y.S., Maher S.E., Bothwell A.L.M., Margulies D.H. T cell receptor-MHC class I peptide interactions. affinity, kinetics, and specificity Science. 265:1994;946-949.
15. Daniels M.A., Jameson S.C. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191:2000;335-346.
16. Daniels M.A., Devine L., Miller J.D., Moser J.M., Lukacher A.E., Altman J.D., Kavathas P., Hogquist K.A., Jameson S.C. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity. 15:2001;1051-1061.
17. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:1998;523-544.
18. Devine L., Sun J., Barr M.R., Kavathas P.B. Orientation of the Ig domains of CD8 alpha beta relative to MHC class I. J. Immunol. 162:1999;846-851.
19. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P. Increased TCR avidity after T cell activation. a mechanism for sensing low-density antigen Immunity. 14:2001;135-143.
20. Gao G.F., Jakobsen B.K. Molecular interactions of coreceptor CD8 and MHC class I. the molecular basis for functional coordination with the T-cell receptor Immunol. Today. 21:2000;630-636.
21. Gao G.F., Willcox B.E., Wyer J.R., Boulter J.M., O'Callaghan C.A., Maenaka K., Stuart D.I., Jones E.Y., Van Der Merwe P.A., Bell J.I.et al. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alpha alpha. J. Biol. Chem. 275:2000;15232-15238.
22. Gao G.F., Rao Z., Bell J.I. Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol. 23:2002;408-413.
23. Garcia K.C., Tallquist M.D., Pease L.R., Brunmark A., Scott C.A., Degano M., Stura E.A., Peterson P.A., Wilson I.A., Teyton L. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands. affinity measurements and crystallization Proc. Natl. Acad. Sci. USA. 94:1997;13838-13843.
24. Gascoigne N.R.J., Zai T., Alam S.M. T-cell receptor binding kinetics in T-cell development and activation. Exp. Rev. Mol. Med. 12(February):2001; http://www-ermm.cbcu.cam.ac.uk/01002502h.htm.
25. Guimezanes A., Barrett-Wilt G.A., Gulden-Thompson P., Shabanowitz J., Engelhard V.H., Hunt D.F., Schmitt-Verhulst A.M., Engelhardt V.H. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes. distinct characteristics correlated with CD8 dependence Eur. J. Immunol. 31:2001;421-432.
26. Hansen T., Balendiran G., Solheim J., Ostrov D., Nathenson S. Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. Immunol. Today. 21:2000;83-88.
27. Holler P.D., Holman P.O., Shusta E.V., O'Herrin S., Wittrup K.D., Kranz D.M. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. USA. 97:2000;5387-5392.
28. Holler P.D., Lim A.R., Cho B.K., Rund L.A., Kranz D.M. CD8-T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J. Exp. Med. 194:2001;1043-1052.
29. Holler P.D., Chlewicki L.K., Kranz D.M. T cell receptors with high affinity for foreign peptide-MHC exhibit self-reactivity. Nat. Immunol. 4:2002;55-62.
30. Kalergis A.M., Boucheron N., Doucey M.A., Palmieri E., Goyarts E.C., Vegh Z., Luescher I.F., Nathenson S.G. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2:2001;229-234.
31. Kersh G.J., Allen P.M. Essential flexibility in the T-cell recognition of antigen. Nature. 380:1996;495-498.
32. Kersh G.J., Kersh E.N., Fremont D.H., Allen P.M. High- and low-potency ligands with similar affinities for the TCR. the importance of kinetics in TCR signaling Immunity. 9:1998;817-826.
33. Lee K.H., Holdorf A.D., Dustin M.L., Chan A.C., Allen P.M., Shaw A.S. T cell receptor signaling precedes immunological synapse formation. Science. 295:2002;1539-1542. a.
34. Lee S., Hori Y., Groves J., Dustin M., Chakraborty A. Correlation of a dynamic model for immunological synapse formation with effector functions. two pathways to synapse formation Trends Immunol. 23:2002;492-499. b.
35. Lee S., Hori Y., Groves J., Dustin M., Chakraborty A. The synapse assembly model. Trends Immunol. 23:2002;500-502. c.
36. Manning T.C., Parke E.A., Teyton L., Kranz D.M. Effects of complementarity determining region mutations on the affinity of an αβ T cell receptor. measuring the energy associated with CD4/CD8 repertoire skewing J. Exp. Med. 189:1999;461-470.
37. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19:1998;395-404.
38. k complexes. correlation of the dissociation rate with T cell responsiveness Proc. Natl. Acad. Sci. USA. 91:1994;12862-12866.
39. McKeithan T.W. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92:1995;5042-5046.
40. Moody A.M., Chui D., Reche P.A., Priatel J.J., Marth J.D., Reinherz E.L. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell. 107:2001;501-512. a.
41. Moody A.M., Xiong Y., Chang H.C., Reinherz E.L. The CD8alphabeta co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur. J. Immunol. 31:2001;2791-2799. b.
42. Parnes J.R. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:1989;265-311.
43. Potter T.A., Grebe K., Freiberg B., Kupfer A. Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells. Proc. Natl. Acad. Sci. USA. 98:2001;12624-12629.
44. Purbhoo M.A., Boulter J.M., Price D.A., Vuidepot A.L., Hourigan C.S., Dunbar P.R., Olson K., Dawson S.J., Phillips R.E., Jakobsen B.K.et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J. Biol. Chem. 276:2001;32786-32792.
45. Reiser J.-B., Darnault C., Guimeezanes A., Gregoire C., Mosser T., Schmitt-Verhulst A.-M., Fontecilla-Camps J.C., Malissen B., Housset D., Mazza G. The crystal strcuture of a TCR bound to an allogeneic MHC molecule. Nat. Immunol. 1:2000;291-297.
46. Renard V., Romero P., Vivier E., Malissen B., Luescher I.F. CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J. Exp. Med. 184:1996;2439-2444.
47. Rosette C., Werlen G., Daniels M.A., Holman P.O., Alam S.M., Travers P.J., Gascoigne N.R., Palmer E., Jameson S.C. The impact of duration versus extent of TCR occupancy on T cell activation. a revision of the kinetic proofreading model Immunity. 15:2001;59-70.
48. Rudolph M.G., Luz J.G., Wilson I.A. Structural and thermodynamic correlates of T cell signaling. Annu. Rev. Biophys. Biomol. Struct. 31:2002;121-149.
49. d and the T cell receptor. J. Immunol. 157:1996;4478-4485.
50. Schodin B.A., Schlueter C.J., Kranz D.M. Binding properties and solubility of single-chain T cell receptors expressed in E. coli. Mol. Immunol. 33:1996;819-829. a.
51. Schodin B.A., Tsomides T.J., Kranz D.M. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity. 5:1996;137-146. b.
52. Sidobre S., Naidenko O.V., Sim B.C., Gascoigne N.R., Garcia K.C., Kronenberg M. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169:2002;1340-1348.
53. Slansky E.J., Rattis M.F., Boyd F.L., Fahmy T., Jaffee M.E., Schneck P.J., Margulies H.D., Pardoll M.D. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity. 13:2000;529-538.
54. d peptide complexes. Immunity. 8:1998;553-562.
55. Tallquist M.D., Weaver A.J., Pease L.R. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J. Immunol. 160:1998;802-809.
56. Valitutti S., Muller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
57. Viola A., Salio M., Tuosto L., Linkert S., Acuto O., Lanzavecchia A. Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J. Exp. Med. 186:1997;1775-1779.
58. Willcox B.E., Gao G.F., Wyer J.R., Ladbury J.E., Bell J.I., Jakobsen B.K., van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 10:1999;357-365.
59. Wyer J.R., Willcox B.E., Gao G.F., Gerth U.C., Davis S.J., Bell J.I., van der Merwe P.A., Jakobsen B.K. T cell receptor and coreceptor CD8αα bind peptide-MHC independently and with distinct kinetics. Immunity. 10:1999;219-225.
60. Xu H., Littman D.R. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell. 74:1993;633-643.
61. Xu X.N., Purbhoo M.A., Chen N., Mongkolsapaya J., Cox J.H., Meier U.C., Tafuro S., Dunbar P.R., Sewell A.K., Hourigan C.S.et al. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using α3 domain mutants of MHC class I/peptide complex. Immunity. 14:2001;591-602.